Is NAD+ a Peptide? What "NAD Peptide" Products Really Are
NAD+ is a coenzyme, not a peptide, despite the "NAD peptide" label sold online. What the molecule is and what human NAD+ injection evidence shows.
The short version
NAD+ is a small coenzyme built from two nucleotides, not a chain of amino acids, so it is not a peptide by any chemical definition. It is sold as IV infusions, injections and oral precursor capsules. Direct human evidence that injecting it delivers the marketed anti-aging, energy or addiction-recovery benefits is thin.
- NAD+ is a dinucleotide coenzyme, structurally unrelated to peptides.
- It gets marketed alongside peptides because it is sold through the same injectable-wellness channel, not because the chemistry overlaps.
- No NAD+ injectable product is FDA-approved for any indication.
- Human trials on direct NAD+ infusion are small and mostly measure tolerability, not the benefits advertised.
No. NAD+ is not a peptide. It is a coenzyme, a small molecule that helps enzymes run chemical reactions, built from two nucleotides. A peptide is a chain of amino acids. The two categories share injections and vendor pages, not a molecular structure. Some vendors label the product “NAD peptide” anyway, but that is a marketing label, not a chemical description.
This page explains what NAD+ actually is, why it turns up next to peptides on research-chemical and IV-clinic menus, and what the human evidence for injecting it shows. For the two side by side, see NAD+ vs peptides.
What NAD+ actually is
NAD+, nicotinamide adenine dinucleotide, is a dinucleotide. It is two nucleotide units, one built on nicotinamide and one on adenine, joined by a pair of phosphate groups. It is not made from amino acids and contains no peptide bond.
Every living cell makes it. It exists in an oxidised form (NAD+) and a reduced form (NADH), and cycles between the two as a hydride-transfer partner in metabolic reactions. Sirtuin and PARP enzymes also consume it when they run their own reactions. This is a genuine, textbook biochemical role, separate from any claim about what injecting extra NAD+ does for a person.
NAD+ next to a peptide, structurally
| NAD+ | A peptide (e.g. BPC-157) | |
|---|---|---|
| Building blocks | Two nucleotides (nicotinamide + adenine) plus two phosphates | Amino acids |
| Bond holding it together | Phosphodiester and glycosidic bonds | Peptide (amide) bonds |
| Molecular class | Dinucleotide coenzyme | Short protein fragment |
| Made by the body already | Yes, in every cell | Some peptides are endogenous, others (like BPC-157) are synthetic sequences not found in the body |
| Typical sale channel on this market | IV-clinic infusions, injections, oral precursor capsules | Vials sold research-use-only, or IV-clinic add-ons |
The last row explains the confusion. NAD+ and injectable peptides are often listed on the same clinic menu or vendor storefront, priced and marketed the same way. That is a commercial grouping, not a chemical one.
What the evidence for NAD+ injections shows
NAD+‘s role inside a cell is well-established biochemistry. What is not established is that adding NAD+ from outside the cell, by IV infusion or injection, produces the benefits advertised: more energy, slower aging, sharper cognition, easier addiction recovery. Vendors routinely blur the two claims. “NAD+ is essential for energy metabolism” is true and says nothing about whether an infusion works.
The human research on direct NAD+ infusion is small. Published work looks mainly at whether an infusion is tolerated and how quickly it clears, in cohorts of a few dozen people at most, over short follow-up windows. That is tolerability data, not efficacy data.
Laboratory and animal research on NAD+ decline and cellular aging is a larger and older body of work. It does not by itself show that raising NAD+ in a person produces a human benefit, the same evidence gap that runs through most research-chemical marketing on this site.
Most of the human trials that report a clear result test oral NAD+ precursors, chiefly nicotinamide riboside, for raising blood NAD+ levels. That is a biomarker change, not a demonstration that a person feels or functions better.
Regulatory status
US legal status - Unapproved drug
No injectable NAD+ product is FDA-approved for any indication. NAD+ IV therapy generally reaches consumers through compounding pharmacies and IV-therapy clinics rather than through the research-use-only labelling common on the peptide market - a distribution channel, not an approval, and one FDA has already taken enforcement action against at least one supplier over it. Oral NAD+ precursor capsules (nicotinamide riboside, nicotinamide mononucleotide) are sold as dietary supplements, which FDA does not review for safety or effectiveness before they reach the market.
The compounding route matters if you are deciding what to expect. A compounded product is not held to the same manufacturing and evidence standard as an FDA-approved drug, whatever a clinic’s marketing implies.
Safety considerations
- Infusion-related reactions (chest tightness, cramping, flushing, nausea) are reported anecdotally and in small tolerability studies of IV NAD+. They are generally described as manageable by slowing the infusion rate. That is not a formal safety profile built from controlled trials.
- No long-term human safety data exist for repeated NAD+ infusion at the doses IV clinics typically use.
- Product quality is not independently verified the way an FDA-approved drug’s is. Potency, sterility and purity depend on the individual compounding pharmacy or clinic.
- This page is not a dosing protocol. Common-practice NAD+ injection doses, labelled as such, are on the NAD+ injection dosage page.
Related guides
- Best NAD+ supplement: NR, NMN and niacin products compared
- NAD+ vs peptides, compared
- What are peptides?
- Research peptides and US law
- Are peptides safe?
Common questions
Is NAD+ a peptide?
No. NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide: two nucleotides joined by a pair of phosphate groups. A peptide is a chain of amino acids joined by peptide bonds. The two molecule classes share no structural feature beyond both being organic compounds the body uses.
Is NAD+ FDA-approved?
No injectable NAD+ product is FDA-approved for any indication. It reaches consumers through compounding pharmacies and IV-therapy clinics, and separately as unregulated oral supplement capsules of NAD+ precursors such as nicotinamide riboside or nicotinamide mononucleotide.
Does NAD+ injection therapy work for anti-aging or energy?
That is not established in humans. NAD+ is a genuine coenzyme with a well-described role in cellular metabolism. But controlled human trials of direct NAD+ infusion are few and small. They mostly measure whether the infusion is tolerated, not whether it produces the energy, anti-aging or recovery effects marketed to consumers.
What is NAD+ peptide good for?
NAD+ is marketed for energy, anti-ageing, cognition and addiction recovery, because the underlying coenzyme has a genuine role in cellular energy metabolism and DNA repair. None of those marketed benefits are established by controlled human trials of direct NAD+ infusion. The human research that exists mostly measures whether the infusion is tolerated, not whether it works.
Is NAD+ like Ozempic?
No. Ozempic is the brand name for semaglutide, an FDA-approved prescription drug first approved in 2017 and updated with new indications since. No NAD+ injectable product is FDA-approved; it reaches consumers through compounding pharmacies, IV clinics and unregulated supplement capsules. The only thing the two share is a sales channel: both get marketed as injectable wellness treatments.
What is the downside of taking NAD+?
The main downsides are an unregulated supply and an unproven benefit, not a well-characterised drug risk. No NAD+ injectable is FDA-approved, so potency and sterility depend on the individual compounding pharmacy or clinic. Infusion-related reactions such as chest tightness, cramping, flushing and nausea are reported anecdotally. No long-term human safety data exist for repeated dosing at the levels IV clinics typically use.
Does NAD+ make you look younger?
There is no controlled human evidence that it does. NAD+ decline is linked to cellular ageing in laboratory and animal research, but no published human trial of NAD+ infusion has measured an anti-ageing or skin-appearance outcome. The human studies that exist measure tolerability, not results.
Does NAD+ cause weight gain?
That has not been studied. No published human trial of NAD+ infusion has reported weight change, gain or loss, as an outcome. The small studies that exist measure tolerability, not body composition. Treat any claim that NAD+ changes weight as unproven either way.
Is NAD+ like Adderall?
No. Adderall is the brand name for a mixture of amphetamine salts, an FDA-approved prescription stimulant. NAD+ is a coenzyme, has no FDA-approved injectable product, and has no stimulant mechanism. The two are unrelated molecules that happen to be searched together.
References (5 sources)
Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.
- 1.FDA - Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act: the three criteria a compounded drug ingredient must meet.- US Food and Drug Administrationregulatory
- 2.NCCIH - Using Dietary Supplements Wisely: rigorous evidence is often lacking for supplement claims, and FDA does not review a supplement for safety before it is marketed.- National Center for Complementary and Integrative Health, NIHother
- 3.FDA warning letter to GenoGenix LLC (WL # 718739, 20 January 2026): NAD+ used in compounding was not an eligible bulk drug substance, and three patients needed emergency treatment after an NAD+ infusion.- US Food and Drug Administrationregulatory
- 4.FDA Drugs@FDA approval overview for OZEMPIC (semaglutide), NDA 209637: originally approved 5 December 2017 as a new molecular entity, with further indication supplements approved since.- US Food and Drug Administrationregulatory
- 5.DailyMed label listing for Adderall: active ingredients are dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate.- National Library of Medicine (DailyMed)label